Cerebrospinal Fluid Biomarkers in Differential Diagnosis of Multiple Sclerosis and Systemic Inflammatory Diseases with Central Nervous System Involvement.

Mariola Świderek-MatysiakMagdalena OsetMalgorzata Domowicz Grazyna GalazkaMagdalena NamiecińskaMariusz Stasiołek

Published in: Biomedicines (2023)

The classical and non-standard markers of inflammatory process and neurodegeneration do not allow for sufficient differentiation between MS and non-MS inflammatory CNS disorders. Weak diagnostic power observed for the osteopontin and NF-L needs to be further investigated.

Keyphrases

multiple sclerosis
cerebrospinal fluid
oxidative stress
mass spectrometry
ms ms
signaling pathway
blood brain barrier
high resolution
atomic force microscopy
toll like receptor
high speed